| Plan Name | VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN |
| Plan identification number | 001 |
| 401k Plan Type | Defined Contribution Pension |
| Plan Features/Benefits |
|
| Company Name: | VERTEX PHARMACEUTICALS |
| Employer identification number (EIN): | 043039129 |
| NAIC Classification: | 541700 |
Additional information about VERTEX PHARMACEUTICALS
| Jurisdiction of Incorporation: | Texas Secretary of State |
| Incorporation Date: | 2011-08-08 |
| Company Identification Number: | 0801463573 |
| Legal Registered Office Address: |
50 NORTHERN AVE BOSTON United States of America (USA) 02210 |
More information about VERTEX PHARMACEUTICALS
| Plan id# | Filing Submission Date | Name of Administrator | Date Administrator Signed | Name of Company Sponsor | Date Sponsor Signed |
|---|---|---|---|---|---|
| 001 | 2024-01-01 | JENNIFER AYLWIN | |||
| 001 | 2023-01-01 | ||||
| 001 | 2023-01-01 | JENNIFER AYLWIN | |||
| 001 | 2022-01-01 | ||||
| 001 | 2022-01-01 | JENNIFER AYLWIN | |||
| 001 | 2021-01-01 | ||||
| 001 | 2021-01-01 | JENNIFER AYLWIN | |||
| 001 | 2020-01-01 | ||||
| 001 | 2019-01-01 | ||||
| 001 | 2018-01-01 | ||||
| 001 | 2017-01-01 | ERICKA LOBERG | |||
| 001 | 2016-01-01 | KRISTINA MORRISSEAU | KRISTINA MORRISSEAU | 2017-09-27 | |
| 001 | 2015-01-01 | KRISTINA MORRISSEAU | |||
| 001 | 2014-01-01 | KRISTINA MORRISSEAU | KRISTINA MORRISSEAU | 2015-08-31 | |
| 001 | 2014-01-01 | KRISTINA MORRISSEAU | |||
| 001 | 2013-01-01 | KATHERINE WILSON | |||
| 001 | 2012-01-01 | THOMAS CONNOLLY | THOMAS CONNOLLY | 2013-07-24 | |
| 001 | 2011-01-01 | LUCINDA GIBBS | |||
| 001 | 2009-01-01 | LUCINDA GIBBS |
| Measure | Date | Value |
|---|---|---|
| 2023 : VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2023 401k financial data | ||
| Unrealized appreciation/depreciation of real estate assets | 2023-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2023-12-31 | $40,503,675 |
| Total unrealized appreciation/depreciation of assets | 2023-12-31 | $40,503,675 |
| Total transfer of assets to this plan | 2023-12-31 | $0 |
| Total transfer of assets from this plan | 2023-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-12-31 | $0 |
| Expenses. Interest paid | 2023-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2023-12-31 | $0 |
| Total income from all sources (including contributions) | 2023-12-31 | $318,552,175 |
| Total loss/gain on sale of assets | 2023-12-31 | $3,019,795 |
| Total of all expenses incurred | 2023-12-31 | $63,837,034 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-12-31 | $63,577,641 |
| Expenses. Certain deemed distributions of participant loans | 2023-12-31 | $0 |
| Value of total corrective distributions | 2023-12-31 | $60,519 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-12-31 | $123,240,960 |
| Value of total assets at end of year | 2023-12-31 | $1,082,606,137 |
| Value of total assets at beginning of year | 2023-12-31 | $827,890,996 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-12-31 | $198,874 |
| Total income from rents | 2023-12-31 | $0 |
| Total interest from all sources | 2023-12-31 | $178,139 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-12-31 | $8,392,750 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2023-12-31 | $8,392,750 |
| Assets. Real estate other than employer real property at end of year | 2023-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2023-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2023-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2023-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2023-12-31 | Yes |
| Value of fidelity bond cover | 2023-12-31 | $5,000,000 |
| If this is an individual account plan, was there a blackout period | 2023-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2023-12-31 | No |
| Contributions received from participants | 2023-12-31 | $63,749,647 |
| Participant contributions at end of year | 2023-12-31 | $3,971,095 |
| Participant contributions at beginning of year | 2023-12-31 | $3,168,910 |
| Participant contributions at end of year | 2023-12-31 | $0 |
| Participant contributions at beginning of year | 2023-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2023-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2023-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2023-12-31 | $25,678,887 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2023-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2023-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2023-12-31 | $0 |
| Assets. Loans (other than to participants) at end of year | 2023-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2023-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2023-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2023-12-31 | $0 |
| Other income not declared elsewhere | 2023-12-31 | $0 |
| Administrative expenses (other) incurred | 2023-12-31 | $0 |
| Liabilities. Value of operating payables at end of year | 2023-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2023-12-31 | $0 |
| Total non interest bearing cash at end of year | 2023-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2023-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Income. Non cash contributions | 2023-12-31 | $0 |
| Value of net income/loss | 2023-12-31 | $254,715,141 |
| Value of net assets at end of year (total assets less liabilities) | 2023-12-31 | $1,082,606,137 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-12-31 | $827,890,996 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2023-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2023-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2023-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2023-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2023-12-31 | $0 |
| Investment advisory and management fees | 2023-12-31 | $30,000 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2023-12-31 | $469,669,472 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2023-12-31 | $359,361,314 |
| Value of interest in pooled separate accounts at end of year | 2023-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2023-12-31 | $0 |
| Interest on participant loans | 2023-12-31 | $178,139 |
| Income. Interest from loans (other than to participants) | 2023-12-31 | $0 |
| Interest earned on other investments | 2023-12-31 | $0 |
| Income. Interest from US Government securities | 2023-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2023-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2023-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2023-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2023-12-31 | $468,049,567 |
| Value of interest in common/collective trusts at beginning of year | 2023-12-31 | $349,118,232 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2023-12-31 | $0 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2023-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2023-12-31 | $0 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2023-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2023-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2023-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2023-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2023-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2023-12-31 | $0 |
| Asset value of US Government securities at end of year | 2023-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2023-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2023-12-31 | $78,895,982 |
| Net investment gain/loss from pooled separate accounts | 2023-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2023-12-31 | $64,320,874 |
| Net gain/loss from 103.12 investment entities | 2023-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2023-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2023-12-31 | No |
| Assets. Invements in employer securities at end of year | 2023-12-31 | $139,536,155 |
| Assets. Invements in employer securities at beginning of year | 2023-12-31 | $110,086,229 |
| Assets. Value of employer real property at end of year | 2023-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2023-12-31 | $0 |
| Contributions received in cash from employer | 2023-12-31 | $33,812,426 |
| Employer contributions (assets) at end of year | 2023-12-31 | $1,379,848 |
| Employer contributions (assets) at beginning of year | 2023-12-31 | $6,156,311 |
| Income. Dividends from preferred stock | 2023-12-31 | $0 |
| Income. Dividends from common stock | 2023-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2023-12-31 | $63,577,641 |
| Asset. Corporate debt instrument preferred debt at end of year | 2023-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2023-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2023-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2023-12-31 | $0 |
| Contract administrator fees | 2023-12-31 | $1,500 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2023-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2023-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2023-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2023-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2023-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2023-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2023-12-31 | $0 |
| Did the plan have assets held for investment | 2023-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2023-12-31 | No |
| Aggregate proceeds on sale of assets | 2023-12-31 | $14,073,544 |
| Aggregate carrying amount (costs) on sale of assets | 2023-12-31 | $11,053,749 |
| Liabilities. Value of acquisition indebtedness at end of year | 2023-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2023-12-31 | $0 |
| Opinion of an independent qualified public accountant for this plan | 2023-12-31 | Unqualified |
| Accountancy firm name | 2023-12-31 | CARON & BLETZER, PLLC |
| Accountancy firm EIN | 2023-12-31 | 043499945 |
| Unrealized appreciation/depreciation of real estate assets | 2023-01-01 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2023-01-01 | $40,503,675 |
| Total unrealized appreciation/depreciation of assets | 2023-01-01 | $40,503,675 |
| Total transfer of assets to this plan | 2023-01-01 | $0 |
| Total transfer of assets from this plan | 2023-01-01 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-01-01 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2023-01-01 | $0 |
| Total income from all sources (including contributions) | 2023-01-01 | $318,552,175 |
| Total loss/gain on sale of assets | 2023-01-01 | $3,019,795 |
| Total of all expenses incurred | 2023-01-01 | $63,837,034 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2023-01-01 | $63,577,641 |
| Expenses. Certain deemed distributions of participant loans | 2023-01-01 | $0 |
| Value of total corrective distributions | 2023-01-01 | $60,519 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2023-01-01 | $123,240,960 |
| Value of total assets at end of year | 2023-01-01 | $1,082,606,137 |
| Value of total assets at beginning of year | 2023-01-01 | $827,890,996 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2023-01-01 | $198,874 |
| Total income from rents | 2023-01-01 | $0 |
| Total interest from all sources | 2023-01-01 | $178,139 |
| Total dividends received (eg from common stock, registered investment company shares) | 2023-01-01 | $8,392,750 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2023-01-01 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2023-01-01 | $8,392,750 |
| Assets. Real estate other than employer real property at end of year | 2023-01-01 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2023-01-01 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2023-01-01 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2023-01-01 | $0 |
| Was this plan covered by a fidelity bond | 2023-01-01 | Yes |
| Value of fidelity bond cover | 2023-01-01 | $5,000,000 |
| If this is an individual account plan, was there a blackout period | 2023-01-01 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2023-01-01 | No |
| Contributions received from participants | 2023-01-01 | $63,749,647 |
| Participant contributions at end of year | 2023-01-01 | $3,971,095 |
| Participant contributions at beginning of year | 2023-01-01 | $3,168,910 |
| Participant contributions at end of year | 2023-01-01 | $0 |
| Participant contributions at beginning of year | 2023-01-01 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2023-01-01 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2023-01-01 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2023-01-01 | $25,678,887 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2023-01-01 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2023-01-01 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2023-01-01 | $0 |
| Assets. Loans (other than to participants) at end of year | 2023-01-01 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2023-01-01 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2023-01-01 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2023-01-01 | $0 |
| Other income not declared elsewhere | 2023-01-01 | $0 |
| Administrative expenses (other) incurred | 2023-01-01 | $0 |
| Liabilities. Value of operating payables at end of year | 2023-01-01 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2023-01-01 | $0 |
| Total non interest bearing cash at end of year | 2023-01-01 | $0 |
| Total non interest bearing cash at beginning of year | 2023-01-01 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-01-01 | No |
| Income. Non cash contributions | 2023-01-01 | $0 |
| Value of net income/loss | 2023-01-01 | $254,715,141 |
| Value of net assets at end of year (total assets less liabilities) | 2023-01-01 | $1,082,606,137 |
| Value of net assets at beginning of year (total assets less liabilities) | 2023-01-01 | $827,890,996 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2023-01-01 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2023-01-01 | No |
| Were any leases to which the plan was party in default or uncollectible | 2023-01-01 | No |
| Assets. partnership/joint venture interests at end of year | 2023-01-01 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2023-01-01 | $0 |
| Investment advisory and management fees | 2023-01-01 | $30,000 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2023-01-01 | $469,669,472 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2023-01-01 | $359,361,314 |
| Value of interest in pooled separate accounts at end of year | 2023-01-01 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2023-01-01 | $0 |
| Interest on participant loans | 2023-01-01 | $178,139 |
| Income. Interest from loans (other than to participants) | 2023-01-01 | $0 |
| Interest earned on other investments | 2023-01-01 | $0 |
| Income. Interest from US Government securities | 2023-01-01 | $0 |
| Income. Interest from corporate debt instruments | 2023-01-01 | $0 |
| Value of interest in master investment trust accounts at end of year | 2023-01-01 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2023-01-01 | $0 |
| Value of interest in common/collective trusts at end of year | 2023-01-01 | $468,049,567 |
| Value of interest in common/collective trusts at beginning of year | 2023-01-01 | $349,118,232 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2023-01-01 | $0 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2023-01-01 | $0 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2023-01-01 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2023-01-01 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2023-01-01 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2023-01-01 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2023-01-01 | $0 |
| Asset value of US Government securities at end of year | 2023-01-01 | $0 |
| Asset value of US Government securities at beginning of year | 2023-01-01 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2023-01-01 | $78,895,982 |
| Net investment gain/loss from pooled separate accounts | 2023-01-01 | $0 |
| Net investment gain or loss from common/collective trusts | 2023-01-01 | $64,320,874 |
| Net gain/loss from 103.12 investment entities | 2023-01-01 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2023-01-01 | No |
| Was there a failure to transmit to the plan any participant contributions | 2023-01-01 | No |
| Has the plan failed to provide any benefit when due under the plan | 2023-01-01 | No |
| Assets. Invements in employer securities at end of year | 2023-01-01 | $139,536,155 |
| Assets. Invements in employer securities at beginning of year | 2023-01-01 | $110,086,229 |
| Assets. Value of employer real property at end of year | 2023-01-01 | $0 |
| Assets. Value of employer real property at beginning of year | 2023-01-01 | $0 |
| Contributions received in cash from employer | 2023-01-01 | $33,812,426 |
| Employer contributions (assets) at end of year | 2023-01-01 | $1,379,848 |
| Employer contributions (assets) at beginning of year | 2023-01-01 | $6,156,311 |
| Income. Dividends from preferred stock | 2023-01-01 | $0 |
| Income. Dividends from common stock | 2023-01-01 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2023-01-01 | $63,577,641 |
| Asset. Corporate debt instrument preferred debt at end of year | 2023-01-01 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2023-01-01 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2023-01-01 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2023-01-01 | $0 |
| Contract administrator fees | 2023-01-01 | $1,500 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2023-01-01 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2023-01-01 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2023-01-01 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2023-01-01 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2023-01-01 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2023-01-01 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2023-01-01 | $0 |
| Did the plan have assets held for investment | 2023-01-01 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2023-01-01 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2023-01-01 | No |
| Aggregate proceeds on sale of assets | 2023-01-01 | $14,073,544 |
| Aggregate carrying amount (costs) on sale of assets | 2023-01-01 | $11,053,749 |
| Liabilities. Value of acquisition indebtedness at end of year | 2023-01-01 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2023-01-01 | $0 |
| Opinion of an independent qualified public accountant for this plan | 2023-01-01 | 1 |
| Accountancy firm name | 2023-01-01 | CARON & BLETZER, PLLC |
| Accountancy firm EIN | 2023-01-01 | 043499945 |
| 2022 : VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2022 401k financial data | ||
| Unrealized appreciation/depreciation of real estate assets | 2022-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2022-12-31 | $26,371,915 |
| Total unrealized appreciation/depreciation of assets | 2022-12-31 | $26,371,915 |
| Total transfer of assets to this plan | 2022-12-31 | $0 |
| Total transfer of assets from this plan | 2022-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-12-31 | $0 |
| Expenses. Interest paid | 2022-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2022-12-31 | $0 |
| Total income from all sources (including contributions) | 2022-12-31 | $-39,797,571 |
| Total loss/gain on sale of assets | 2022-12-31 | $1,208,514 |
| Total of all expenses incurred | 2022-12-31 | $57,338,991 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-12-31 | $56,977,466 |
| Expenses. Certain deemed distributions of participant loans | 2022-12-31 | $4,522 |
| Value of total corrective distributions | 2022-12-31 | $29,123 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-12-31 | $97,522,384 |
| Value of total assets at end of year | 2022-12-31 | $827,890,996 |
| Value of total assets at beginning of year | 2022-12-31 | $925,027,558 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-12-31 | $327,880 |
| Total income from rents | 2022-12-31 | $0 |
| Total interest from all sources | 2022-12-31 | $117,695 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-12-31 | $24,645,410 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2022-12-31 | $24,645,410 |
| Assets. Real estate other than employer real property at end of year | 2022-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2022-12-31 | $0 |
| Administrative expenses professional fees incurred | 2022-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2022-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2022-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2022-12-31 | Yes |
| Value of fidelity bond cover | 2022-12-31 | $5,000,000 |
| If this is an individual account plan, was there a blackout period | 2022-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2022-12-31 | No |
| Contributions received from participants | 2022-12-31 | $50,482,427 |
| Participant contributions at end of year | 2022-12-31 | $3,168,910 |
| Participant contributions at beginning of year | 2022-12-31 | $2,912,703 |
| Participant contributions at end of year | 2022-12-31 | $0 |
| Participant contributions at beginning of year | 2022-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2022-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2022-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2022-12-31 | $20,326,925 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2022-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-12-31 | $0 |
| Assets. Loans (other than to participants) at end of year | 2022-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2022-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2022-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2022-12-31 | $0 |
| Other income not declared elsewhere | 2022-12-31 | $0 |
| Administrative expenses (other) incurred | 2022-12-31 | $327,880 |
| Liabilities. Value of operating payables at end of year | 2022-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2022-12-31 | $0 |
| Total non interest bearing cash at end of year | 2022-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2022-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Income. Non cash contributions | 2022-12-31 | $0 |
| Value of net income/loss | 2022-12-31 | $-97,136,562 |
| Value of net assets at end of year (total assets less liabilities) | 2022-12-31 | $827,890,996 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-12-31 | $925,027,558 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2022-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2022-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2022-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2022-12-31 | $0 |
| Investment advisory and management fees | 2022-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-12-31 | $359,361,314 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-12-31 | $805,942,288 |
| Value of interest in pooled separate accounts at end of year | 2022-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2022-12-31 | $0 |
| Interest on participant loans | 2022-12-31 | $117,695 |
| Income. Interest from loans (other than to participants) | 2022-12-31 | $0 |
| Interest earned on other investments | 2022-12-31 | $0 |
| Income. Interest from US Government securities | 2022-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2022-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2022-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2022-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2022-12-31 | $349,118,232 |
| Value of interest in common/collective trusts at beginning of year | 2022-12-31 | $22,718,396 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2022-12-31 | $0 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2022-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2022-12-31 | $0 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2022-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2022-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2022-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2022-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2022-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2022-12-31 | $0 |
| Asset value of US Government securities at end of year | 2022-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2022-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-12-31 | $-187,594,658 |
| Net investment gain/loss from pooled separate accounts | 2022-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2022-12-31 | $-2,068,831 |
| Net gain/loss from 103.12 investment entities | 2022-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2022-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2022-12-31 | No |
| Assets. Invements in employer securities at end of year | 2022-12-31 | $110,086,229 |
| Assets. Invements in employer securities at beginning of year | 2022-12-31 | $88,608,079 |
| Assets. Value of employer real property at end of year | 2022-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2022-12-31 | $0 |
| Contributions received in cash from employer | 2022-12-31 | $26,713,032 |
| Employer contributions (assets) at end of year | 2022-12-31 | $6,156,311 |
| Employer contributions (assets) at beginning of year | 2022-12-31 | $4,846,092 |
| Income. Dividends from preferred stock | 2022-12-31 | $0 |
| Income. Dividends from common stock | 2022-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-12-31 | $56,977,466 |
| Asset. Corporate debt instrument preferred debt at end of year | 2022-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2022-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2022-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2022-12-31 | $0 |
| Contract administrator fees | 2022-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2022-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2022-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2022-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2022-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2022-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2022-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2022-12-31 | $0 |
| Did the plan have assets held for investment | 2022-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-12-31 | No |
| Aggregate proceeds on sale of assets | 2022-12-31 | $6,102,278 |
| Aggregate carrying amount (costs) on sale of assets | 2022-12-31 | $4,893,764 |
| Liabilities. Value of acquisition indebtedness at end of year | 2022-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2022-12-31 | $0 |
| Opinion of an independent qualified public accountant for this plan | 2022-12-31 | Unqualified |
| Accountancy firm name | 2022-12-31 | CARON & BLETZER, PLLC |
| Accountancy firm EIN | 2022-12-31 | 043499945 |
| Unrealized appreciation/depreciation of real estate assets | 2022-01-01 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2022-01-01 | $26,371,915 |
| Total unrealized appreciation/depreciation of assets | 2022-01-01 | $26,371,915 |
| Total transfer of assets to this plan | 2022-01-01 | $0 |
| Total transfer of assets from this plan | 2022-01-01 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-01-01 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2022-01-01 | $0 |
| Total income from all sources (including contributions) | 2022-01-01 | $-39,797,571 |
| Total loss/gain on sale of assets | 2022-01-01 | $1,208,514 |
| Total of all expenses incurred | 2022-01-01 | $57,338,991 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2022-01-01 | $56,977,466 |
| Expenses. Certain deemed distributions of participant loans | 2022-01-01 | $4,522 |
| Value of total corrective distributions | 2022-01-01 | $29,123 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2022-01-01 | $97,522,384 |
| Value of total assets at end of year | 2022-01-01 | $827,890,996 |
| Value of total assets at beginning of year | 2022-01-01 | $925,027,558 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2022-01-01 | $327,880 |
| Total income from rents | 2022-01-01 | $0 |
| Total interest from all sources | 2022-01-01 | $117,695 |
| Total dividends received (eg from common stock, registered investment company shares) | 2022-01-01 | $24,645,410 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2022-01-01 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2022-01-01 | $24,645,410 |
| Assets. Real estate other than employer real property at end of year | 2022-01-01 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2022-01-01 | $0 |
| Administrative expenses professional fees incurred | 2022-01-01 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2022-01-01 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2022-01-01 | $0 |
| Was this plan covered by a fidelity bond | 2022-01-01 | Yes |
| Value of fidelity bond cover | 2022-01-01 | $5,000,000 |
| If this is an individual account plan, was there a blackout period | 2022-01-01 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2022-01-01 | No |
| Contributions received from participants | 2022-01-01 | $50,482,427 |
| Participant contributions at end of year | 2022-01-01 | $3,168,910 |
| Participant contributions at beginning of year | 2022-01-01 | $2,912,703 |
| Participant contributions at end of year | 2022-01-01 | $0 |
| Participant contributions at beginning of year | 2022-01-01 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2022-01-01 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2022-01-01 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2022-01-01 | $20,326,925 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2022-01-01 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2022-01-01 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2022-01-01 | $0 |
| Assets. Loans (other than to participants) at end of year | 2022-01-01 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2022-01-01 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2022-01-01 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2022-01-01 | $0 |
| Other income not declared elsewhere | 2022-01-01 | $0 |
| Administrative expenses (other) incurred | 2022-01-01 | $327,880 |
| Liabilities. Value of operating payables at end of year | 2022-01-01 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2022-01-01 | $0 |
| Total non interest bearing cash at end of year | 2022-01-01 | $0 |
| Total non interest bearing cash at beginning of year | 2022-01-01 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-01-01 | No |
| Income. Non cash contributions | 2022-01-01 | $0 |
| Value of net income/loss | 2022-01-01 | $-97,136,562 |
| Value of net assets at end of year (total assets less liabilities) | 2022-01-01 | $827,890,996 |
| Value of net assets at beginning of year (total assets less liabilities) | 2022-01-01 | $925,027,558 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2022-01-01 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2022-01-01 | No |
| Were any leases to which the plan was party in default or uncollectible | 2022-01-01 | No |
| Assets. partnership/joint venture interests at end of year | 2022-01-01 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2022-01-01 | $0 |
| Investment advisory and management fees | 2022-01-01 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2022-01-01 | $359,361,314 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2022-01-01 | $805,942,288 |
| Value of interest in pooled separate accounts at end of year | 2022-01-01 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2022-01-01 | $0 |
| Interest on participant loans | 2022-01-01 | $117,695 |
| Income. Interest from loans (other than to participants) | 2022-01-01 | $0 |
| Interest earned on other investments | 2022-01-01 | $0 |
| Income. Interest from US Government securities | 2022-01-01 | $0 |
| Income. Interest from corporate debt instruments | 2022-01-01 | $0 |
| Value of interest in master investment trust accounts at end of year | 2022-01-01 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2022-01-01 | $0 |
| Value of interest in common/collective trusts at end of year | 2022-01-01 | $349,118,232 |
| Value of interest in common/collective trusts at beginning of year | 2022-01-01 | $22,718,396 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2022-01-01 | $0 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2022-01-01 | $0 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2022-01-01 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2022-01-01 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2022-01-01 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2022-01-01 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2022-01-01 | $0 |
| Asset value of US Government securities at end of year | 2022-01-01 | $0 |
| Asset value of US Government securities at beginning of year | 2022-01-01 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2022-01-01 | $-187,594,658 |
| Net investment gain/loss from pooled separate accounts | 2022-01-01 | $0 |
| Net investment gain or loss from common/collective trusts | 2022-01-01 | $-2,068,831 |
| Net gain/loss from 103.12 investment entities | 2022-01-01 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2022-01-01 | No |
| Was there a failure to transmit to the plan any participant contributions | 2022-01-01 | No |
| Has the plan failed to provide any benefit when due under the plan | 2022-01-01 | No |
| Assets. Invements in employer securities at end of year | 2022-01-01 | $110,086,229 |
| Assets. Invements in employer securities at beginning of year | 2022-01-01 | $88,608,079 |
| Assets. Value of employer real property at end of year | 2022-01-01 | $0 |
| Assets. Value of employer real property at beginning of year | 2022-01-01 | $0 |
| Contributions received in cash from employer | 2022-01-01 | $26,713,032 |
| Employer contributions (assets) at end of year | 2022-01-01 | $6,156,311 |
| Employer contributions (assets) at beginning of year | 2022-01-01 | $4,846,092 |
| Income. Dividends from preferred stock | 2022-01-01 | $0 |
| Income. Dividends from common stock | 2022-01-01 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2022-01-01 | $56,977,466 |
| Asset. Corporate debt instrument preferred debt at end of year | 2022-01-01 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2022-01-01 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2022-01-01 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2022-01-01 | $0 |
| Contract administrator fees | 2022-01-01 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2022-01-01 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2022-01-01 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2022-01-01 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2022-01-01 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2022-01-01 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2022-01-01 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2022-01-01 | $0 |
| Did the plan have assets held for investment | 2022-01-01 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2022-01-01 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2022-01-01 | No |
| Aggregate proceeds on sale of assets | 2022-01-01 | $6,102,278 |
| Aggregate carrying amount (costs) on sale of assets | 2022-01-01 | $4,893,764 |
| Liabilities. Value of acquisition indebtedness at end of year | 2022-01-01 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2022-01-01 | $0 |
| Opinion of an independent qualified public accountant for this plan | 2022-01-01 | 1 |
| Accountancy firm name | 2022-01-01 | CARON & BLETZER, PLLC |
| Accountancy firm EIN | 2022-01-01 | 043499945 |
| 2021 : VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2021 401k financial data | ||
| Unrealized appreciation/depreciation of real estate assets | 2021-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2021-12-31 | $-6,754,430 |
| Total unrealized appreciation/depreciation of assets | 2021-12-31 | $-6,754,430 |
| Total transfer of assets to this plan | 2021-12-31 | $0 |
| Total transfer of assets from this plan | 2021-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2021-12-31 | $0 |
| Expenses. Interest paid | 2021-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2021-12-31 | $0 |
| Total income from all sources (including contributions) | 2021-12-31 | $184,607,766 |
| Total loss/gain on sale of assets | 2021-12-31 | $-699,509 |
| Total of all expenses incurred | 2021-12-31 | $56,335,158 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2021-12-31 | $56,119,354 |
| Expenses. Certain deemed distributions of participant loans | 2021-12-31 | $0 |
| Value of total corrective distributions | 2021-12-31 | $51,845 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2021-12-31 | $78,374,273 |
| Value of total assets at end of year | 2021-12-31 | $925,027,558 |
| Value of total assets at beginning of year | 2021-12-31 | $796,754,950 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2021-12-31 | $163,959 |
| Total income from rents | 2021-12-31 | $0 |
| Total interest from all sources | 2021-12-31 | $125,258 |
| Total dividends received (eg from common stock, registered investment company shares) | 2021-12-31 | $65,246,708 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2021-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2021-12-31 | $65,246,708 |
| Assets. Real estate other than employer real property at end of year | 2021-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2021-12-31 | $0 |
| Administrative expenses professional fees incurred | 2021-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2021-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2021-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2021-12-31 | Yes |
| Value of fidelity bond cover | 2021-12-31 | $5,000,000 |
| If this is an individual account plan, was there a blackout period | 2021-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2021-12-31 | No |
| Contributions received from participants | 2021-12-31 | $41,852,102 |
| Participant contributions at end of year | 2021-12-31 | $2,912,703 |
| Participant contributions at beginning of year | 2021-12-31 | $2,668,152 |
| Participant contributions at end of year | 2021-12-31 | $0 |
| Participant contributions at beginning of year | 2021-12-31 | $747,842 |
| Assets. Other investments not covered elsewhere at end of year | 2021-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2021-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2021-12-31 | $14,948,825 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2021-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2021-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2021-12-31 | $0 |
| Assets. Loans (other than to participants) at end of year | 2021-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2021-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2021-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2021-12-31 | $0 |
| Other income not declared elsewhere | 2021-12-31 | $0 |
| Administrative expenses (other) incurred | 2021-12-31 | $163,959 |
| Liabilities. Value of operating payables at end of year | 2021-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2021-12-31 | $0 |
| Total non interest bearing cash at end of year | 2021-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2021-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
| Income. Non cash contributions | 2021-12-31 | $0 |
| Value of net income/loss | 2021-12-31 | $128,272,608 |
| Value of net assets at end of year (total assets less liabilities) | 2021-12-31 | $925,027,558 |
| Value of net assets at beginning of year (total assets less liabilities) | 2021-12-31 | $796,754,950 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2021-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2021-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2021-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2021-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2021-12-31 | $0 |
| Investment advisory and management fees | 2021-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2021-12-31 | $805,942,288 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2021-12-31 | $661,825,519 |
| Value of interest in pooled separate accounts at end of year | 2021-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2021-12-31 | $0 |
| Interest on participant loans | 2021-12-31 | $125,258 |
| Income. Interest from loans (other than to participants) | 2021-12-31 | $0 |
| Interest earned on other investments | 2021-12-31 | $0 |
| Income. Interest from US Government securities | 2021-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2021-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2021-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2021-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2021-12-31 | $22,718,396 |
| Value of interest in common/collective trusts at beginning of year | 2021-12-31 | $26,297,177 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2021-12-31 | $0 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2021-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2021-12-31 | $0 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2021-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2021-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2021-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2021-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2021-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2021-12-31 | $0 |
| Asset value of US Government securities at end of year | 2021-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2021-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2021-12-31 | $48,760,314 |
| Net investment gain/loss from pooled separate accounts | 2021-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2021-12-31 | $-444,848 |
| Net gain/loss from 103.12 investment entities | 2021-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2021-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2021-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2021-12-31 | No |
| Assets. Invements in employer securities at end of year | 2021-12-31 | $88,608,079 |
| Assets. Invements in employer securities at beginning of year | 2021-12-31 | $101,149,180 |
| Assets. Value of employer real property at end of year | 2021-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2021-12-31 | $0 |
| Contributions received in cash from employer | 2021-12-31 | $21,573,346 |
| Employer contributions (assets) at end of year | 2021-12-31 | $4,846,092 |
| Employer contributions (assets) at beginning of year | 2021-12-31 | $4,067,080 |
| Income. Dividends from preferred stock | 2021-12-31 | $0 |
| Income. Dividends from common stock | 2021-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2021-12-31 | $56,119,354 |
| Asset. Corporate debt instrument preferred debt at end of year | 2021-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2021-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2021-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2021-12-31 | $0 |
| Contract administrator fees | 2021-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2021-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2021-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2021-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2021-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2021-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2021-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2021-12-31 | $0 |
| Did the plan have assets held for investment | 2021-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2021-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2021-12-31 | No |
| Aggregate proceeds on sale of assets | 2021-12-31 | $5,087,161 |
| Aggregate carrying amount (costs) on sale of assets | 2021-12-31 | $5,786,670 |
| Liabilities. Value of acquisition indebtedness at end of year | 2021-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2021-12-31 | $0 |
| Opinion of an independent qualified public accountant for this plan | 2021-12-31 | Unqualified |
| Accountancy firm name | 2021-12-31 | CARON & BLETZER, PLLC |
| Accountancy firm EIN | 2021-12-31 | 043499945 |
| 2020 : VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2020 401k financial data | ||
| Unrealized appreciation/depreciation of real estate assets | 2020-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2020-12-31 | $7,442,263 |
| Total unrealized appreciation/depreciation of assets | 2020-12-31 | $7,442,263 |
| Total transfer of assets to this plan | 2020-12-31 | $0 |
| Total transfer of assets from this plan | 2020-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2020-12-31 | $0 |
| Expenses. Interest paid | 2020-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2020-12-31 | $0 |
| Total income from all sources (including contributions) | 2020-12-31 | $186,591,145 |
| Total loss/gain on sale of assets | 2020-12-31 | $731,461 |
| Total of all expenses incurred | 2020-12-31 | $32,337,657 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2020-12-31 | $32,589,669 |
| Expenses. Certain deemed distributions of participant loans | 2020-12-31 | $0 |
| Value of total corrective distributions | 2020-12-31 | $28,952 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2020-12-31 | $68,801,566 |
| Value of total assets at end of year | 2020-12-31 | $796,754,950 |
| Value of total assets at beginning of year | 2020-12-31 | $642,501,462 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2020-12-31 | $-280,964 |
| Total income from rents | 2020-12-31 | $0 |
| Total interest from all sources | 2020-12-31 | $111,189 |
| Total dividends received (eg from common stock, registered investment company shares) | 2020-12-31 | $32,189,216 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2020-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2020-12-31 | $32,189,216 |
| Assets. Real estate other than employer real property at end of year | 2020-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2020-12-31 | $0 |
| Administrative expenses professional fees incurred | 2020-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2020-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2020-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2020-12-31 | Yes |
| Value of fidelity bond cover | 2020-12-31 | $5,000,000 |
| If this is an individual account plan, was there a blackout period | 2020-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2020-12-31 | No |
| Contributions received from participants | 2020-12-31 | $37,565,421 |
| Participant contributions at end of year | 2020-12-31 | $2,668,152 |
| Participant contributions at beginning of year | 2020-12-31 | $2,613,455 |
| Participant contributions at end of year | 2020-12-31 | $747,842 |
| Participant contributions at beginning of year | 2020-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2020-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2020-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2020-12-31 | $11,852,277 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2020-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2020-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2020-12-31 | $270,070 |
| Assets. Loans (other than to participants) at end of year | 2020-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2020-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2020-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2020-12-31 | $0 |
| Other income not declared elsewhere | 2020-12-31 | $0 |
| Administrative expenses (other) incurred | 2020-12-31 | $-280,964 |
| Liabilities. Value of operating payables at end of year | 2020-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2020-12-31 | $0 |
| Total non interest bearing cash at end of year | 2020-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2020-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
| Income. Non cash contributions | 2020-12-31 | $0 |
| Value of net income/loss | 2020-12-31 | $154,253,488 |
| Value of net assets at end of year (total assets less liabilities) | 2020-12-31 | $796,754,950 |
| Value of net assets at beginning of year (total assets less liabilities) | 2020-12-31 | $642,501,462 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2020-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2020-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2020-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2020-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2020-12-31 | $0 |
| Investment advisory and management fees | 2020-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2020-12-31 | $661,825,519 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2020-12-31 | $519,423,438 |
| Value of interest in pooled separate accounts at end of year | 2020-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2020-12-31 | $0 |
| Interest on participant loans | 2020-12-31 | $111,189 |
| Income. Interest from loans (other than to participants) | 2020-12-31 | $0 |
| Interest earned on other investments | 2020-12-31 | $0 |
| Income. Interest from US Government securities | 2020-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2020-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2020-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2020-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2020-12-31 | $26,297,177 |
| Value of interest in common/collective trusts at beginning of year | 2020-12-31 | $18,930,743 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2020-12-31 | $0 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2020-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2020-12-31 | $0 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2020-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2020-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2020-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at end of year | 2020-12-31 | $0 |
| Value of funds held in insurance company general accounts (unallocated contracts) at beginning of year | 2020-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2020-12-31 | $0 |
| Asset value of US Government securities at end of year | 2020-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2020-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2020-12-31 | $76,317,072 |
| Net investment gain/loss from pooled separate accounts | 2020-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2020-12-31 | $998,378 |
| Net gain/loss from 103.12 investment entities | 2020-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2020-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2020-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2020-12-31 | No |
| Assets. Invements in employer securities at end of year | 2020-12-31 | $101,149,180 |
| Assets. Invements in employer securities at beginning of year | 2020-12-31 | $98,279,021 |
| Assets. Value of employer real property at end of year | 2020-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2020-12-31 | $0 |
| Contributions received in cash from employer | 2020-12-31 | $19,383,868 |
| Employer contributions (assets) at end of year | 2020-12-31 | $4,067,080 |
| Employer contributions (assets) at beginning of year | 2020-12-31 | $2,984,735 |
| Income. Dividends from preferred stock | 2020-12-31 | $0 |
| Income. Dividends from common stock | 2020-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2020-12-31 | $32,589,669 |
| Asset. Corporate debt instrument preferred debt at end of year | 2020-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2020-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2020-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2020-12-31 | $0 |
| Contract administrator fees | 2020-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2020-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2020-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2020-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2020-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2020-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2020-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2020-12-31 | $0 |
| Did the plan have assets held for investment | 2020-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2020-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2020-12-31 | No |
| Aggregate proceeds on sale of assets | 2020-12-31 | $5,303,565 |
| Aggregate carrying amount (costs) on sale of assets | 2020-12-31 | $4,572,104 |
| Liabilities. Value of acquisition indebtedness at end of year | 2020-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2020-12-31 | $0 |
| Opinion of an independent qualified public accountant for this plan | 2020-12-31 | Unqualified |
| Accountancy firm name | 2020-12-31 | CITRIN COOPERMAN & COMPANY, LLP |
| Accountancy firm EIN | 2020-12-31 | 222428965 |
| 2019 : VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2019 401k financial data | ||
| Unrealized appreciation/depreciation of real estate assets | 2019-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2019-12-31 | $23,897,538 |
| Total unrealized appreciation/depreciation of assets | 2019-12-31 | $23,897,538 |
| Total transfer of assets to this plan | 2019-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2019-12-31 | $0 |
| Expenses. Interest paid | 2019-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2019-12-31 | $0 |
| Total income from all sources (including contributions) | 2019-12-31 | $186,375,245 |
| Total loss/gain on sale of assets | 2019-12-31 | $775,272 |
| Total of all expenses incurred | 2019-12-31 | $38,028,292 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2019-12-31 | $38,234,568 |
| Expenses. Certain deemed distributions of participant loans | 2019-12-31 | $0 |
| Value of total corrective distributions | 2019-12-31 | $21,849 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2019-12-31 | $56,279,344 |
| Value of total assets at end of year | 2019-12-31 | $642,501,462 |
| Value of total assets at beginning of year | 2019-12-31 | $494,154,509 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2019-12-31 | $-228,125 |
| Total income from rents | 2019-12-31 | $0 |
| Total interest from all sources | 2019-12-31 | $101,969 |
| Total dividends received (eg from common stock, registered investment company shares) | 2019-12-31 | $22,523,791 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2019-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2019-12-31 | $22,523,791 |
| Assets. Real estate other than employer real property at end of year | 2019-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2019-12-31 | $0 |
| Administrative expenses professional fees incurred | 2019-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2019-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2019-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2019-12-31 | Yes |
| Value of fidelity bond cover | 2019-12-31 | $5,000,000 |
| If this is an individual account plan, was there a blackout period | 2019-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2019-12-31 | No |
| Contributions received from participants | 2019-12-31 | $30,791,951 |
| Participant contributions at end of year | 2019-12-31 | $2,613,455 |
| Participant contributions at beginning of year | 2019-12-31 | $1,961,547 |
| Participant contributions at end of year | 2019-12-31 | $0 |
| Participant contributions at beginning of year | 2019-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2019-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2019-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2019-12-31 | $9,729,347 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2019-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2019-12-31 | $270,070 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2019-12-31 | $0 |
| Assets. Loans (other than to participants) at end of year | 2019-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2019-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2019-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2019-12-31 | $0 |
| Other income not declared elsewhere | 2019-12-31 | $0 |
| Administrative expenses (other) incurred | 2019-12-31 | $-228,125 |
| Liabilities. Value of operating payables at end of year | 2019-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2019-12-31 | $0 |
| Total non interest bearing cash at end of year | 2019-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2019-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
| Income. Non cash contributions | 2019-12-31 | $0 |
| Value of net income/loss | 2019-12-31 | $148,346,953 |
| Value of net assets at end of year (total assets less liabilities) | 2019-12-31 | $642,501,462 |
| Value of net assets at beginning of year (total assets less liabilities) | 2019-12-31 | $494,154,509 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2019-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2019-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2019-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2019-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2019-12-31 | $0 |
| Investment advisory and management fees | 2019-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2019-12-31 | $519,423,438 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2019-12-31 | $391,945,358 |
| Value of interest in pooled separate accounts at end of year | 2019-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2019-12-31 | $0 |
| Interest on participant loans | 2019-12-31 | $101,969 |
| Income. Interest from loans (other than to participants) | 2019-12-31 | $0 |
| Interest earned on other investments | 2019-12-31 | $0 |
| Income. Interest from US Government securities | 2019-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2019-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2019-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2019-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2019-12-31 | $18,930,743 |
| Value of interest in common/collective trusts at beginning of year | 2019-12-31 | $18,307,117 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2019-12-31 | $0 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2019-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2019-12-31 | $0 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2019-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2019-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2019-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2019-12-31 | $0 |
| Asset value of US Government securities at end of year | 2019-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2019-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2019-12-31 | $81,986,400 |
| Net investment gain/loss from pooled separate accounts | 2019-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2019-12-31 | $810,931 |
| Net gain/loss from 103.12 investment entities | 2019-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2019-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2019-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2019-12-31 | No |
| Assets. Invements in employer securities at end of year | 2019-12-31 | $98,279,021 |
| Assets. Invements in employer securities at beginning of year | 2019-12-31 | $79,445,773 |
| Assets. Value of employer real property at end of year | 2019-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2019-12-31 | $0 |
| Contributions received in cash from employer | 2019-12-31 | $15,758,046 |
| Employer contributions (assets) at end of year | 2019-12-31 | $2,984,735 |
| Employer contributions (assets) at beginning of year | 2019-12-31 | $2,494,714 |
| Income. Dividends from preferred stock | 2019-12-31 | $0 |
| Income. Dividends from common stock | 2019-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2019-12-31 | $38,234,568 |
| Asset. Corporate debt instrument preferred debt at end of year | 2019-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2019-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2019-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2019-12-31 | $0 |
| Contract administrator fees | 2019-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2019-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2019-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2019-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2019-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2019-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2019-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2019-12-31 | $0 |
| Did the plan have assets held for investment | 2019-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2019-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2019-12-31 | No |
| Aggregate proceeds on sale of assets | 2019-12-31 | $5,839,561 |
| Aggregate carrying amount (costs) on sale of assets | 2019-12-31 | $5,064,289 |
| Liabilities. Value of acquisition indebtedness at end of year | 2019-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2019-12-31 | $0 |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2019-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2019-12-31 | Disclaimer |
| Accountancy firm name | 2019-12-31 | CITRIN COOPERMAN & COMPANY, LLP |
| Accountancy firm EIN | 2019-12-31 | 222428965 |
| 2018 : VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2018 401k financial data | ||
| Unrealized appreciation/depreciation of real estate assets | 2018-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2018-12-31 | $7,598,923 |
| Total unrealized appreciation/depreciation of assets | 2018-12-31 | $7,598,923 |
| Total transfer of assets to this plan | 2018-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2018-12-31 | $0 |
| Expenses. Interest paid | 2018-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2018-12-31 | $0 |
| Total income from all sources (including contributions) | 2018-12-31 | $26,428,065 |
| Total loss/gain on sale of assets | 2018-12-31 | $653,487 |
| Total of all expenses incurred | 2018-12-31 | $35,142,673 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2018-12-31 | $35,293,449 |
| Expenses. Certain deemed distributions of participant loans | 2018-12-31 | $0 |
| Value of total corrective distributions | 2018-12-31 | $52,453 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2018-12-31 | $48,628,962 |
| Value of total assets at end of year | 2018-12-31 | $494,154,509 |
| Value of total assets at beginning of year | 2018-12-31 | $502,869,117 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2018-12-31 | $-203,229 |
| Total income from rents | 2018-12-31 | $0 |
| Total interest from all sources | 2018-12-31 | $78,429 |
| Total dividends received (eg from common stock, registered investment company shares) | 2018-12-31 | $24,641,275 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2018-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2018-12-31 | $24,641,275 |
| Assets. Real estate other than employer real property at end of year | 2018-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2018-12-31 | $0 |
| Administrative expenses professional fees incurred | 2018-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2018-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2018-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2018-12-31 | Yes |
| Value of fidelity bond cover | 2018-12-31 | $5,000,000 |
| If this is an individual account plan, was there a blackout period | 2018-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2018-12-31 | No |
| Contributions received from participants | 2018-12-31 | $26,841,472 |
| Participant contributions at end of year | 2018-12-31 | $1,961,547 |
| Participant contributions at beginning of year | 2018-12-31 | $2,138,524 |
| Participant contributions at end of year | 2018-12-31 | $0 |
| Participant contributions at beginning of year | 2018-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2018-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2018-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2018-12-31 | $7,977,198 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2018-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2018-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2018-12-31 | $0 |
| Assets. Loans (other than to participants) at end of year | 2018-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2018-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2018-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2018-12-31 | $0 |
| Other income not declared elsewhere | 2018-12-31 | $0 |
| Administrative expenses (other) incurred | 2018-12-31 | $-203,229 |
| Liabilities. Value of operating payables at end of year | 2018-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2018-12-31 | $0 |
| Total non interest bearing cash at end of year | 2018-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2018-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
| Income. Non cash contributions | 2018-12-31 | $0 |
| Value of net income/loss | 2018-12-31 | $-8,714,608 |
| Value of net assets at end of year (total assets less liabilities) | 2018-12-31 | $494,154,509 |
| Value of net assets at beginning of year (total assets less liabilities) | 2018-12-31 | $502,869,117 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2018-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2018-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2018-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2018-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2018-12-31 | $0 |
| Investment advisory and management fees | 2018-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2018-12-31 | $391,945,358 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2018-12-31 | $405,645,874 |
| Value of interest in pooled separate accounts at end of year | 2018-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2018-12-31 | $0 |
| Interest on participant loans | 2018-12-31 | $78,429 |
| Income. Interest from loans (other than to participants) | 2018-12-31 | $0 |
| Interest earned on other investments | 2018-12-31 | $0 |
| Income. Interest from US Government securities | 2018-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2018-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2018-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2018-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2018-12-31 | $18,307,117 |
| Value of interest in common/collective trusts at beginning of year | 2018-12-31 | $15,588,216 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2018-12-31 | $0 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2018-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2018-12-31 | $0 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2018-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2018-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2018-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2018-12-31 | $0 |
| Asset value of US Government securities at end of year | 2018-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2018-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2018-12-31 | $-55,280,160 |
| Net investment gain/loss from pooled separate accounts | 2018-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2018-12-31 | $107,149 |
| Net gain/loss from 103.12 investment entities | 2018-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2018-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2018-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2018-12-31 | No |
| Assets. Invements in employer securities at end of year | 2018-12-31 | $79,445,773 |
| Assets. Invements in employer securities at beginning of year | 2018-12-31 | $77,168,834 |
| Assets. Value of employer real property at end of year | 2018-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2018-12-31 | $0 |
| Contributions received in cash from employer | 2018-12-31 | $13,810,292 |
| Employer contributions (assets) at end of year | 2018-12-31 | $2,494,714 |
| Employer contributions (assets) at beginning of year | 2018-12-31 | $2,327,669 |
| Income. Dividends from preferred stock | 2018-12-31 | $0 |
| Income. Dividends from common stock | 2018-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2018-12-31 | $35,293,449 |
| Asset. Corporate debt instrument preferred debt at end of year | 2018-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2018-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2018-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2018-12-31 | $0 |
| Contract administrator fees | 2018-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2018-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2018-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2018-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2018-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2018-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2018-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2018-12-31 | $0 |
| Did the plan have assets held for investment | 2018-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2018-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2018-12-31 | No |
| Aggregate proceeds on sale of assets | 2018-12-31 | $5,975,471 |
| Aggregate carrying amount (costs) on sale of assets | 2018-12-31 | $5,321,984 |
| Liabilities. Value of acquisition indebtedness at end of year | 2018-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2018-12-31 | $0 |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2018-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2018-12-31 | Disclaimer |
| Accountancy firm name | 2018-12-31 | CITRIN COOPERMAN & COMPANY, LLP |
| Accountancy firm EIN | 2018-12-31 | 222428965 |
| 2017 : VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2017 401k financial data | ||
| Unrealized appreciation/depreciation of real estate assets | 2017-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2017-12-31 | $39,232,870 |
| Total unrealized appreciation/depreciation of assets | 2017-12-31 | $39,232,870 |
| Total transfer of assets to this plan | 2017-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2017-12-31 | $0 |
| Expenses. Interest paid | 2017-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2017-12-31 | $0 |
| Total income from all sources (including contributions) | 2017-12-31 | $150,686,595 |
| Total loss/gain on sale of assets | 2017-12-31 | $2,137,594 |
| Total of all expenses incurred | 2017-12-31 | $34,586,252 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2017-12-31 | $34,658,046 |
| Expenses. Certain deemed distributions of participant loans | 2017-12-31 | $0 |
| Value of total corrective distributions | 2017-12-31 | $31,454 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2017-12-31 | $41,313,451 |
| Value of total assets at end of year | 2017-12-31 | $502,869,117 |
| Value of total assets at beginning of year | 2017-12-31 | $386,768,774 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2017-12-31 | $-103,248 |
| Total income from rents | 2017-12-31 | $0 |
| Total interest from all sources | 2017-12-31 | $68,139 |
| Total dividends received (eg from common stock, registered investment company shares) | 2017-12-31 | $19,928,795 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2017-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2017-12-31 | $19,928,795 |
| Assets. Real estate other than employer real property at end of year | 2017-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2017-12-31 | $0 |
| Administrative expenses professional fees incurred | 2017-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2017-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2017-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2017-12-31 | Yes |
| Value of fidelity bond cover | 2017-12-31 | $5,000,000 |
| If this is an individual account plan, was there a blackout period | 2017-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2017-12-31 | No |
| Contributions received from participants | 2017-12-31 | $23,635,610 |
| Participant contributions at end of year | 2017-12-31 | $2,138,524 |
| Participant contributions at beginning of year | 2017-12-31 | $1,762,371 |
| Participant contributions at end of year | 2017-12-31 | $0 |
| Participant contributions at beginning of year | 2017-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2017-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2017-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2017-12-31 | $5,525,100 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2017-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2017-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2017-12-31 | $0 |
| Assets. Loans (other than to participants) at end of year | 2017-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2017-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2017-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2017-12-31 | $0 |
| Other income not declared elsewhere | 2017-12-31 | $0 |
| Administrative expenses (other) incurred | 2017-12-31 | $-103,248 |
| Liabilities. Value of operating payables at end of year | 2017-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2017-12-31 | $0 |
| Total non interest bearing cash at end of year | 2017-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2017-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
| Income. Non cash contributions | 2017-12-31 | $0 |
| Value of net income/loss | 2017-12-31 | $116,100,343 |
| Value of net assets at end of year (total assets less liabilities) | 2017-12-31 | $502,869,117 |
| Value of net assets at beginning of year (total assets less liabilities) | 2017-12-31 | $386,768,774 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2017-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2017-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2017-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2017-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2017-12-31 | $0 |
| Investment advisory and management fees | 2017-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2017-12-31 | $405,645,874 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2017-12-31 | $326,195,048 |
| Value of interest in pooled separate accounts at end of year | 2017-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2017-12-31 | $0 |
| Interest on participant loans | 2017-12-31 | $68,139 |
| Income. Interest from loans (other than to participants) | 2017-12-31 | $0 |
| Interest earned on other investments | 2017-12-31 | $0 |
| Income. Interest from US Government securities | 2017-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2017-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2017-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2017-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2017-12-31 | $15,588,216 |
| Value of interest in common/collective trusts at beginning of year | 2017-12-31 | $15,879,277 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2017-12-31 | $0 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2017-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2017-12-31 | $0 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2017-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2017-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2017-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2017-12-31 | $0 |
| Asset value of US Government securities at end of year | 2017-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2017-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2017-12-31 | $47,889,187 |
| Net investment gain/loss from pooled separate accounts | 2017-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2017-12-31 | $116,559 |
| Net gain/loss from 103.12 investment entities | 2017-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2017-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2017-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2017-12-31 | No |
| Assets. Invements in employer securities at end of year | 2017-12-31 | $77,168,834 |
| Assets. Invements in employer securities at beginning of year | 2017-12-31 | $40,924,779 |
| Assets. Value of employer real property at end of year | 2017-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2017-12-31 | $0 |
| Contributions received in cash from employer | 2017-12-31 | $12,152,741 |
| Employer contributions (assets) at end of year | 2017-12-31 | $2,327,669 |
| Employer contributions (assets) at beginning of year | 2017-12-31 | $2,007,299 |
| Income. Dividends from preferred stock | 2017-12-31 | $0 |
| Income. Dividends from common stock | 2017-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2017-12-31 | $34,658,046 |
| Asset. Corporate debt instrument preferred debt at end of year | 2017-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2017-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2017-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2017-12-31 | $0 |
| Contract administrator fees | 2017-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2017-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2017-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2017-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2017-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2017-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2017-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2017-12-31 | $0 |
| Did the plan have assets held for investment | 2017-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2017-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2017-12-31 | No |
| Aggregate proceeds on sale of assets | 2017-12-31 | $5,126,409 |
| Aggregate carrying amount (costs) on sale of assets | 2017-12-31 | $2,988,815 |
| Liabilities. Value of acquisition indebtedness at end of year | 2017-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2017-12-31 | $0 |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2017-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2017-12-31 | Disclaimer |
| Accountancy firm name | 2017-12-31 | CITRIN COOPERMAN & COMPANY, LLP |
| Accountancy firm EIN | 2017-12-31 | 222428965 |
| 2016 : VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2016 401k financial data | ||
| Unrealized appreciation/depreciation of real estate assets | 2016-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2016-12-31 | $-28,974,269 |
| Total unrealized appreciation/depreciation of assets | 2016-12-31 | $-28,974,269 |
| Total transfer of assets to this plan | 2016-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2016-12-31 | $0 |
| Expenses. Interest paid | 2016-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2016-12-31 | $0 |
| Total income from all sources (including contributions) | 2016-12-31 | $32,366,356 |
| Total loss/gain on sale of assets | 2016-12-31 | $-1,269,264 |
| Total of all expenses incurred | 2016-12-31 | $27,606,139 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2016-12-31 | $27,707,758 |
| Expenses. Certain deemed distributions of participant loans | 2016-12-31 | $0 |
| Value of total corrective distributions | 2016-12-31 | $14,789 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2016-12-31 | $36,615,253 |
| Value of total assets at end of year | 2016-12-31 | $386,768,774 |
| Value of total assets at beginning of year | 2016-12-31 | $382,008,557 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2016-12-31 | $-116,408 |
| Total income from rents | 2016-12-31 | $0 |
| Total interest from all sources | 2016-12-31 | $57,558 |
| Total dividends received (eg from common stock, registered investment company shares) | 2016-12-31 | $10,527,375 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2016-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2016-12-31 | $10,527,375 |
| Assets. Real estate other than employer real property at end of year | 2016-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2016-12-31 | $0 |
| Administrative expenses professional fees incurred | 2016-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2016-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2016-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2016-12-31 | Yes |
| Value of fidelity bond cover | 2016-12-31 | $5,000,000 |
| If this is an individual account plan, was there a blackout period | 2016-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2016-12-31 | No |
| Contributions received from participants | 2016-12-31 | $21,528,244 |
| Participant contributions at end of year | 2016-12-31 | $1,762,371 |
| Participant contributions at beginning of year | 2016-12-31 | $1,539,707 |
| Participant contributions at end of year | 2016-12-31 | $0 |
| Participant contributions at beginning of year | 2016-12-31 | $413,249 |
| Assets. Other investments not covered elsewhere at end of year | 2016-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2016-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2016-12-31 | $3,929,079 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2016-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2016-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2016-12-31 | $0 |
| Assets. Loans (other than to participants) at end of year | 2016-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2016-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2016-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2016-12-31 | $0 |
| Other income not declared elsewhere | 2016-12-31 | $0 |
| Administrative expenses (other) incurred | 2016-12-31 | $-116,408 |
| Liabilities. Value of operating payables at end of year | 2016-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2016-12-31 | $0 |
| Total non interest bearing cash at end of year | 2016-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2016-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
| Income. Non cash contributions | 2016-12-31 | $0 |
| Value of net income/loss | 2016-12-31 | $4,760,217 |
| Value of net assets at end of year (total assets less liabilities) | 2016-12-31 | $386,768,774 |
| Value of net assets at beginning of year (total assets less liabilities) | 2016-12-31 | $382,008,557 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2016-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2016-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2016-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2016-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2016-12-31 | $0 |
| Investment advisory and management fees | 2016-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2016-12-31 | $326,195,048 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2016-12-31 | $288,832,862 |
| Value of interest in pooled separate accounts at end of year | 2016-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2016-12-31 | $0 |
| Interest on participant loans | 2016-12-31 | $57,558 |
| Income. Interest from loans (other than to participants) | 2016-12-31 | $0 |
| Interest earned on other investments | 2016-12-31 | $0 |
| Income. Interest from US Government securities | 2016-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2016-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2016-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2016-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2016-12-31 | $15,879,277 |
| Value of interest in common/collective trusts at beginning of year | 2016-12-31 | $15,013,088 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2016-12-31 | $0 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2016-12-31 | $0 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2016-12-31 | $0 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2016-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2016-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2016-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2016-12-31 | $0 |
| Asset value of US Government securities at end of year | 2016-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2016-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2016-12-31 | $15,281,831 |
| Net investment gain/loss from pooled separate accounts | 2016-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2016-12-31 | $127,872 |
| Net gain/loss from 103.12 investment entities | 2016-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2016-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2016-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2016-12-31 | No |
| Assets. Invements in employer securities at end of year | 2016-12-31 | $40,924,779 |
| Assets. Invements in employer securities at beginning of year | 2016-12-31 | $74,032,829 |
| Assets. Value of employer real property at end of year | 2016-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2016-12-31 | $0 |
| Contributions received in cash from employer | 2016-12-31 | $11,157,930 |
| Employer contributions (assets) at end of year | 2016-12-31 | $2,007,299 |
| Employer contributions (assets) at beginning of year | 2016-12-31 | $2,176,822 |
| Income. Dividends from preferred stock | 2016-12-31 | $0 |
| Income. Dividends from common stock | 2016-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2016-12-31 | $27,707,758 |
| Asset. Corporate debt instrument preferred debt at end of year | 2016-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2016-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2016-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2016-12-31 | $0 |
| Contract administrator fees | 2016-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2016-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2016-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2016-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2016-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2016-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2016-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2016-12-31 | $0 |
| Did the plan have assets held for investment | 2016-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2016-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2016-12-31 | No |
| Aggregate proceeds on sale of assets | 2016-12-31 | $2,864,518 |
| Aggregate carrying amount (costs) on sale of assets | 2016-12-31 | $4,133,782 |
| Liabilities. Value of acquisition indebtedness at end of year | 2016-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2016-12-31 | $0 |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2016-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2016-12-31 | Disclaimer |
| Accountancy firm name | 2016-12-31 | CITRIN COOPERMAN & COMPANY, LLP |
| Accountancy firm EIN | 2016-12-31 | 222428965 |
| 2015 : VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2015 401k financial data | ||
| Unrealized appreciation/depreciation of real estate assets | 2015-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2015-12-31 | $4,052,012 |
| Total unrealized appreciation/depreciation of assets | 2015-12-31 | $4,052,012 |
| Total transfer of assets to this plan | 2015-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2015-12-31 | $97,549 |
| Expenses. Interest paid | 2015-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2015-12-31 | $0 |
| Total income from all sources (including contributions) | 2015-12-31 | $38,028,398 |
| Total loss/gain on sale of assets | 2015-12-31 | $477,941 |
| Total of all expenses incurred | 2015-12-31 | $25,421,999 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2015-12-31 | $25,544,277 |
| Expenses. Certain deemed distributions of participant loans | 2015-12-31 | $0 |
| Value of total corrective distributions | 2015-12-31 | $10,699 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2015-12-31 | $33,694,362 |
| Value of total assets at end of year | 2015-12-31 | $382,008,557 |
| Value of total assets at beginning of year | 2015-12-31 | $369,499,707 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2015-12-31 | $-132,977 |
| Total income from rents | 2015-12-31 | $0 |
| Total interest from all sources | 2015-12-31 | $57,437 |
| Total dividends received (eg from common stock, registered investment company shares) | 2015-12-31 | $14,895,274 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2015-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2015-12-31 | $14,895,274 |
| Assets. Real estate other than employer real property at end of year | 2015-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2015-12-31 | $0 |
| Administrative expenses professional fees incurred | 2015-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2015-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2015-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2015-12-31 | Yes |
| Value of fidelity bond cover | 2015-12-31 | $5,000,000 |
| If this is an individual account plan, was there a blackout period | 2015-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2015-12-31 | No |
| Contributions received from participants | 2015-12-31 | $20,204,165 |
| Participant contributions at end of year | 2015-12-31 | $1,539,707 |
| Participant contributions at beginning of year | 2015-12-31 | $1,753,113 |
| Participant contributions at end of year | 2015-12-31 | $413,249 |
| Participant contributions at beginning of year | 2015-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2015-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2015-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2015-12-31 | $3,251,587 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2015-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2015-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2015-12-31 | $74 |
| Assets. Loans (other than to participants) at end of year | 2015-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2015-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2015-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2015-12-31 | $0 |
| Other income not declared elsewhere | 2015-12-31 | $0 |
| Administrative expenses (other) incurred | 2015-12-31 | $-132,977 |
| Liabilities. Value of operating payables at end of year | 2015-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2015-12-31 | $0 |
| Total non interest bearing cash at end of year | 2015-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2015-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2015-12-31 | No |
| Income. Non cash contributions | 2015-12-31 | $0 |
| Value of net income/loss | 2015-12-31 | $12,606,399 |
| Value of net assets at end of year (total assets less liabilities) | 2015-12-31 | $382,008,557 |
| Value of net assets at beginning of year (total assets less liabilities) | 2015-12-31 | $369,402,158 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2015-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2015-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2015-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2015-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2015-12-31 | $0 |
| Investment advisory and management fees | 2015-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2015-12-31 | $288,832,862 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2015-12-31 | $273,617,283 |
| Value of interest in pooled separate accounts at end of year | 2015-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2015-12-31 | $0 |
| Interest on participant loans | 2015-12-31 | $55,961 |
| Income. Interest from loans (other than to participants) | 2015-12-31 | $0 |
| Interest earned on other investments | 2015-12-31 | $0 |
| Income. Interest from US Government securities | 2015-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2015-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2015-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2015-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2015-12-31 | $15,013,088 |
| Value of interest in common/collective trusts at beginning of year | 2015-12-31 | $14,956,146 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2015-12-31 | $0 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2015-12-31 | $1,349,864 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2015-12-31 | $1,349,864 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2015-12-31 | $1,476 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2015-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2015-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2015-12-31 | $0 |
| Asset value of US Government securities at end of year | 2015-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2015-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2015-12-31 | $-15,201,957 |
| Net investment gain/loss from pooled separate accounts | 2015-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2015-12-31 | $53,329 |
| Net gain/loss from 103.12 investment entities | 2015-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2015-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2015-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2015-12-31 | No |
| Assets. Invements in employer securities at end of year | 2015-12-31 | $74,032,829 |
| Assets. Invements in employer securities at beginning of year | 2015-12-31 | $75,838,356 |
| Assets. Value of employer real property at end of year | 2015-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2015-12-31 | $0 |
| Contributions received in cash from employer | 2015-12-31 | $10,238,610 |
| Employer contributions (assets) at end of year | 2015-12-31 | $2,176,822 |
| Employer contributions (assets) at beginning of year | 2015-12-31 | $1,984,871 |
| Income. Dividends from preferred stock | 2015-12-31 | $0 |
| Income. Dividends from common stock | 2015-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2015-12-31 | $25,544,277 |
| Asset. Corporate debt instrument preferred debt at end of year | 2015-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2015-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2015-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2015-12-31 | $0 |
| Contract administrator fees | 2015-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2015-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2015-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2015-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2015-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2015-12-31 | $97,549 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2015-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2015-12-31 | $0 |
| Did the plan have assets held for investment | 2015-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2015-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2015-12-31 | No |
| Aggregate proceeds on sale of assets | 2015-12-31 | $7,617,821 |
| Aggregate carrying amount (costs) on sale of assets | 2015-12-31 | $7,139,880 |
| Liabilities. Value of acquisition indebtedness at end of year | 2015-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2015-12-31 | $0 |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2015-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2015-12-31 | Disclaimer |
| Accountancy firm name | 2015-12-31 | KIRKLAND ALBRECHT & FREDRICKSON LLC |
| Accountancy firm EIN | 2015-12-31 | 043121055 |
| 2014 : VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2014 401k financial data | ||
| Unrealized appreciation/depreciation of real estate assets | 2014-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2014-12-31 | $28,431,061 |
| Total unrealized appreciation/depreciation of assets | 2014-12-31 | $28,431,061 |
| Total transfer of assets to this plan | 2014-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $97,549 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2014-12-31 | $175,463 |
| Expenses. Interest paid | 2014-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2014-12-31 | $0 |
| Total income from all sources (including contributions) | 2014-12-31 | $77,473,905 |
| Total loss/gain on sale of assets | 2014-12-31 | $2,708,481 |
| Total of all expenses incurred | 2014-12-31 | $34,658,318 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2014-12-31 | $34,636,170 |
| Expenses. Certain deemed distributions of participant loans | 2014-12-31 | $9,610 |
| Value of total corrective distributions | 2014-12-31 | $3,325 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2014-12-31 | $27,960,957 |
| Value of total assets at end of year | 2014-12-31 | $367,514,836 |
| Value of total assets at beginning of year | 2014-12-31 | $324,777,163 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2014-12-31 | $9,213 |
| Total income from rents | 2014-12-31 | $0 |
| Total interest from all sources | 2014-12-31 | $66,309 |
| Total dividends received (eg from common stock, registered investment company shares) | 2014-12-31 | $17,412,939 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2014-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2014-12-31 | $17,412,939 |
| Assets. Real estate other than employer real property at end of year | 2014-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2014-12-31 | $0 |
| Administrative expenses professional fees incurred | 2014-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2014-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2014-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2014-12-31 | Yes |
| Value of fidelity bond cover | 2014-12-31 | $5,000,000 |
| If this is an individual account plan, was there a blackout period | 2014-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2014-12-31 | No |
| Contributions received from participants | 2014-12-31 | $18,395,537 |
| Participant contributions at end of year | 2014-12-31 | $1,753,113 |
| Participant contributions at beginning of year | 2014-12-31 | $2,167,290 |
| Participant contributions at end of year | 2014-12-31 | $0 |
| Participant contributions at beginning of year | 2014-12-31 | $0 |
| Assets. Other investments not covered elsewhere at end of year | 2014-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2014-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2014-12-31 | $2,031,668 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2014-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2014-12-31 | $74 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2014-12-31 | $370,919 |
| Assets. Loans (other than to participants) at end of year | 2014-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2014-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2014-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2014-12-31 | $0 |
| Other income not declared elsewhere | 2014-12-31 | $0 |
| Administrative expenses (other) incurred | 2014-12-31 | $9,213 |
| Liabilities. Value of operating payables at end of year | 2014-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2014-12-31 | $0 |
| Total non interest bearing cash at end of year | 2014-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2014-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2014-12-31 | No |
| Income. Non cash contributions | 2014-12-31 | $0 |
| Value of net income/loss | 2014-12-31 | $42,815,587 |
| Value of net assets at end of year (total assets less liabilities) | 2014-12-31 | $367,417,287 |
| Value of net assets at beginning of year (total assets less liabilities) | 2014-12-31 | $324,601,700 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2014-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2014-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2014-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2014-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2014-12-31 | $0 |
| Investment advisory and management fees | 2014-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2014-12-31 | $273,617,283 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2014-12-31 | $245,342,652 |
| Value of interest in pooled separate accounts at end of year | 2014-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2014-12-31 | $0 |
| Interest on participant loans | 2014-12-31 | $65,857 |
| Income. Interest from loans (other than to participants) | 2014-12-31 | $0 |
| Interest earned on other investments | 2014-12-31 | $0 |
| Income. Interest from US Government securities | 2014-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2014-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2014-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2014-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2014-12-31 | $14,956,146 |
| Value of interest in common/collective trusts at beginning of year | 2014-12-31 | $13,458,653 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2014-12-31 | $1,349,864 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2014-12-31 | $851,507 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2014-12-31 | $851,507 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2014-12-31 | $452 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2014-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2014-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2014-12-31 | $0 |
| Asset value of US Government securities at end of year | 2014-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2014-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2014-12-31 | $740,202 |
| Net investment gain/loss from pooled separate accounts | 2014-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2014-12-31 | $153,956 |
| Net gain/loss from 103.12 investment entities | 2014-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2014-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2014-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2014-12-31 | No |
| Assets. Invements in employer securities at end of year | 2014-12-31 | $75,838,356 |
| Assets. Invements in employer securities at beginning of year | 2014-12-31 | $60,217,921 |
| Assets. Value of employer real property at end of year | 2014-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2014-12-31 | $0 |
| Contributions received in cash from employer | 2014-12-31 | $7,533,752 |
| Employer contributions (assets) at end of year | 2014-12-31 | $0 |
| Employer contributions (assets) at beginning of year | 2014-12-31 | $2,368,221 |
| Income. Dividends from preferred stock | 2014-12-31 | $0 |
| Income. Dividends from common stock | 2014-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2014-12-31 | $34,636,170 |
| Asset. Corporate debt instrument preferred debt at end of year | 2014-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2014-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2014-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2014-12-31 | $0 |
| Contract administrator fees | 2014-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2014-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2014-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2014-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2014-12-31 | $97,549 |
| Liabilities. Value of benefit claims payable at beginning of year | 2014-12-31 | $175,463 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2014-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2014-12-31 | $0 |
| Did the plan have assets held for investment | 2014-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2014-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2014-12-31 | No |
| Aggregate proceeds on sale of assets | 2014-12-31 | $15,495,511 |
| Aggregate carrying amount (costs) on sale of assets | 2014-12-31 | $12,787,030 |
| Liabilities. Value of acquisition indebtedness at end of year | 2014-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2014-12-31 | $0 |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2014-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2014-12-31 | Disclaimer |
| Accountancy firm name | 2014-12-31 | KIRKLAND ALBRECHT & FREDRICKSON LLC |
| Accountancy firm EIN | 2014-12-31 | 043121055 |
| 2013 : VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2013 401k financial data | ||
| Unrealized appreciation/depreciation of real estate assets | 2013-12-31 | $0 |
| Unrealized appreciation/depreciation of other (non real estate) assets | 2013-12-31 | $24,737,082 |
| Total unrealized appreciation/depreciation of assets | 2013-12-31 | $24,737,082 |
| Total transfer of assets to this plan | 2013-12-31 | $0 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $175,463 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2013-12-31 | $31,313 |
| Expenses. Interest paid | 2013-12-31 | $0 |
| Amount of participant contributions which was failed to transmit to the plan within the time period described in 29 CFR 251.3-102 | 2013-12-31 | $0 |
| Total income from all sources (including contributions) | 2013-12-31 | $112,685,306 |
| Total loss/gain on sale of assets | 2013-12-31 | $8,759,687 |
| Total of all expenses incurred | 2013-12-31 | $22,859,631 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2013-12-31 | $22,844,620 |
| Expenses. Certain deemed distributions of participant loans | 2013-12-31 | $0 |
| Value of total corrective distributions | 2013-12-31 | $2,067 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2013-12-31 | $35,129,532 |
| Value of total assets at end of year | 2013-12-31 | $324,777,163 |
| Value of total assets at beginning of year | 2013-12-31 | $234,807,338 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2013-12-31 | $12,944 |
| Total income from rents | 2013-12-31 | $0 |
| Total interest from all sources | 2013-12-31 | $88,866 |
| Total dividends received (eg from common stock, registered investment company shares) | 2013-12-31 | $9,399,935 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2013-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2013-12-31 | $9,399,935 |
| Assets. Real estate other than employer real property at end of year | 2013-12-31 | $0 |
| Assets. Real estate other than employer real property at beginning of year | 2013-12-31 | $0 |
| Administrative expenses professional fees incurred | 2013-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at end of year | 2013-12-31 | $0 |
| Assets. Corporate prefeered stocks other than exployer securities at beginning of year | 2013-12-31 | $0 |
| Was this plan covered by a fidelity bond | 2013-12-31 | Yes |
| Value of fidelity bond cover | 2013-12-31 | $5,000,000 |
| If this is an individual account plan, was there a blackout period | 2013-12-31 | No |
| Were there any nonexempt tranactions with any party-in-interest | 2013-12-31 | No |
| Contributions received from participants | 2013-12-31 | $21,084,114 |
| Participant contributions at end of year | 2013-12-31 | $2,167,290 |
| Participant contributions at beginning of year | 2013-12-31 | $2,397,622 |
| Participant contributions at end of year | 2013-12-31 | $0 |
| Participant contributions at beginning of year | 2013-12-31 | $512,193 |
| Assets. Other investments not covered elsewhere at end of year | 2013-12-31 | $0 |
| Assets. Other investments not covered elsewhere at beginning of year | 2013-12-31 | $0 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2013-12-31 | $3,228,410 |
| Expenses. Other payments made (not to insurance carriers or or participants/beneficiaries) | 2013-12-31 | $0 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2013-12-31 | $370,919 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2013-12-31 | $81 |
| Assets. Loans (other than to participants) at end of year | 2013-12-31 | $0 |
| Assets. Loans (other than to participants) at beginning of year | 2013-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at end of year | 2013-12-31 | $0 |
| Other liabilities (not benefit claims, operating payabales oe acquisition indebtedness) at beginning of year | 2013-12-31 | $0 |
| Other income not declared elsewhere | 2013-12-31 | $0 |
| Administrative expenses (other) incurred | 2013-12-31 | $12,944 |
| Liabilities. Value of operating payables at end of year | 2013-12-31 | $0 |
| Liabilities. Value of operating payables at beginning of year | 2013-12-31 | $0 |
| Total non interest bearing cash at end of year | 2013-12-31 | $0 |
| Total non interest bearing cash at beginning of year | 2013-12-31 | $0 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2013-12-31 | No |
| Income. Non cash contributions | 2013-12-31 | $0 |
| Value of net income/loss | 2013-12-31 | $89,825,675 |
| Value of net assets at end of year (total assets less liabilities) | 2013-12-31 | $324,601,700 |
| Value of net assets at beginning of year (total assets less liabilities) | 2013-12-31 | $234,776,025 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2013-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2013-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2013-12-31 | No |
| Assets. partnership/joint venture interests at end of year | 2013-12-31 | $0 |
| Assets. partnership/joint venture interests at beginning of year | 2013-12-31 | $0 |
| Investment advisory and management fees | 2013-12-31 | $0 |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2013-12-31 | $245,342,652 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2013-12-31 | $174,318,052 |
| Value of interest in pooled separate accounts at end of year | 2013-12-31 | $0 |
| Value of interest in pooled separate accounts at beginning of year | 2013-12-31 | $0 |
| Interest on participant loans | 2013-12-31 | $88,183 |
| Income. Interest from loans (other than to participants) | 2013-12-31 | $0 |
| Interest earned on other investments | 2013-12-31 | $0 |
| Income. Interest from US Government securities | 2013-12-31 | $0 |
| Income. Interest from corporate debt instruments | 2013-12-31 | $0 |
| Value of interest in master investment trust accounts at end of year | 2013-12-31 | $0 |
| Value of interest in master investment trust accounts at beginning of year | 2013-12-31 | $0 |
| Value of interest in common/collective trusts at end of year | 2013-12-31 | $13,458,653 |
| Value of interest in common/collective trusts at beginning of year | 2013-12-31 | $11,769,088 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2013-12-31 | $851,507 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2013-12-31 | $744,432 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2013-12-31 | $744,432 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2013-12-31 | $683 |
| Assets. Value of investments in 103.12 investment entities at end of year | 2013-12-31 | $0 |
| Assets. Value of investments in 103.12 investment entities at beginning of year | 2013-12-31 | $0 |
| Expenses. Payments to insurance carriers foe the provision of benefits | 2013-12-31 | $0 |
| Asset value of US Government securities at end of year | 2013-12-31 | $0 |
| Asset value of US Government securities at beginning of year | 2013-12-31 | $0 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2013-12-31 | $34,558,824 |
| Net investment gain/loss from pooled separate accounts | 2013-12-31 | $0 |
| Net investment gain or loss from common/collective trusts | 2013-12-31 | $11,380 |
| Net gain/loss from 103.12 investment entities | 2013-12-31 | $0 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2013-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2013-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2013-12-31 | No |
| Assets. Invements in employer securities at end of year | 2013-12-31 | $60,217,921 |
| Assets. Invements in employer securities at beginning of year | 2013-12-31 | $42,535,632 |
| Assets. Value of employer real property at end of year | 2013-12-31 | $0 |
| Assets. Value of employer real property at beginning of year | 2013-12-31 | $0 |
| Contributions received in cash from employer | 2013-12-31 | $10,817,008 |
| Employer contributions (assets) at end of year | 2013-12-31 | $2,368,221 |
| Employer contributions (assets) at beginning of year | 2013-12-31 | $2,530,238 |
| Income. Dividends from preferred stock | 2013-12-31 | $0 |
| Income. Dividends from common stock | 2013-12-31 | $0 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2013-12-31 | $22,844,620 |
| Asset. Corporate debt instrument preferred debt at end of year | 2013-12-31 | $0 |
| Asset. Corporate debt instrument preferred debt at beginning of year | 2013-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at end of year | 2013-12-31 | $0 |
| Asset. Corporate debt instrument debt (other) at beginning of year | 2013-12-31 | $0 |
| Contract administrator fees | 2013-12-31 | $0 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2013-12-31 | No |
| Assets. Corporate common stocks other than exployer securities at end of year | 2013-12-31 | $0 |
| Assets. Corporate common stocks other than exployer securities at beginning of year | 2013-12-31 | $0 |
| Liabilities. Value of benefit claims payable at end of year | 2013-12-31 | $175,463 |
| Liabilities. Value of benefit claims payable at beginning of year | 2013-12-31 | $31,313 |
| Assets. Value of buildings and other operty used in plan operation at end of year | 2013-12-31 | $0 |
| Assets. Value of buildings and other operty used in plan operation at beginning of year | 2013-12-31 | $0 |
| Did the plan have assets held for investment | 2013-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2013-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2013-12-31 | No |
| Aggregate proceeds on sale of assets | 2013-12-31 | $21,744,780 |
| Aggregate carrying amount (costs) on sale of assets | 2013-12-31 | $12,985,093 |
| Liabilities. Value of acquisition indebtedness at end of year | 2013-12-31 | $0 |
| Liabilities. Value of acquisition indebtedness at beginning of year | 2013-12-31 | $0 |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2013-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2013-12-31 | Disclaimer |
| Accountancy firm name | 2013-12-31 | KIRKLAND ALBRECHT & FREDRICKSON LLC |
| Accountancy firm EIN | 2013-12-31 | 043121055 |
| 2012 : VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2012 401k financial data | ||
| Unrealized appreciation/depreciation of other (non real estate) assets | 2012-12-31 | $6,849,357 |
| Total unrealized appreciation/depreciation of assets | 2012-12-31 | $6,849,357 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-12-31 | $31,313 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2012-12-31 | $0 |
| Total income from all sources (including contributions) | 2012-12-31 | $71,897,276 |
| Total loss/gain on sale of assets | 2012-12-31 | $7,141,889 |
| Total of all expenses incurred | 2012-12-31 | $12,342,009 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2012-12-31 | $12,282,469 |
| Expenses. Certain deemed distributions of participant loans | 2012-12-31 | $26,682 |
| Value of total corrective distributions | 2012-12-31 | $21,870 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2012-12-31 | $37,166,185 |
| Value of total assets at end of year | 2012-12-31 | $234,807,338 |
| Value of total assets at beginning of year | 2012-12-31 | $175,220,758 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2012-12-31 | $10,988 |
| Total interest from all sources | 2012-12-31 | $88,339 |
| Total dividends received (eg from common stock, registered investment company shares) | 2012-12-31 | $5,091,504 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2012-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2012-12-31 | $5,091,504 |
| Was this plan covered by a fidelity bond | 2012-12-31 | Yes |
| Value of fidelity bond cover | 2012-12-31 | $5,000,000 |
| If this is an individual account plan, was there a blackout period | 2012-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2012-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2012-12-31 | No |
| Contributions received from participants | 2012-12-31 | $19,916,210 |
| Participant contributions at end of year | 2012-12-31 | $2,397,622 |
| Participant contributions at beginning of year | 2012-12-31 | $1,879,070 |
| Participant contributions at end of year | 2012-12-31 | $512,193 |
| Participant contributions at beginning of year | 2012-12-31 | $411,172 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2012-12-31 | $6,750,210 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2012-12-31 | $81 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2012-12-31 | $92 |
| Administrative expenses (other) incurred | 2012-12-31 | $10,988 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2012-12-31 | No |
| Value of net income/loss | 2012-12-31 | $59,555,267 |
| Value of net assets at end of year (total assets less liabilities) | 2012-12-31 | $234,776,025 |
| Value of net assets at beginning of year (total assets less liabilities) | 2012-12-31 | $175,220,758 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2012-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2012-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2012-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2012-12-31 | $174,318,052 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2012-12-31 | $123,419,399 |
| Interest on participant loans | 2012-12-31 | $86,938 |
| Value of interest in common/collective trusts at end of year | 2012-12-31 | $11,769,088 |
| Value of interest in common/collective trusts at beginning of year | 2012-12-31 | $10,005,005 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2012-12-31 | $744,432 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2012-12-31 | $714,131 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2012-12-31 | $714,131 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2012-12-31 | $1,401 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2012-12-31 | $15,338,580 |
| Net investment gain or loss from common/collective trusts | 2012-12-31 | $221,422 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2012-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2012-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2012-12-31 | No |
| Assets. Invements in employer securities at end of year | 2012-12-31 | $42,535,632 |
| Assets. Invements in employer securities at beginning of year | 2012-12-31 | $36,500,015 |
| Contributions received in cash from employer | 2012-12-31 | $10,499,765 |
| Employer contributions (assets) at end of year | 2012-12-31 | $2,530,238 |
| Employer contributions (assets) at beginning of year | 2012-12-31 | $2,291,874 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2012-12-31 | $12,282,469 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2012-12-31 | No |
| Liabilities. Value of benefit claims payable at end of year | 2012-12-31 | $31,313 |
| Liabilities. Value of benefit claims payable at beginning of year | 2012-12-31 | $0 |
| Did the plan have assets held for investment | 2012-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2012-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2012-12-31 | No |
| Aggregate proceeds on sale of assets | 2012-12-31 | $18,217,033 |
| Aggregate carrying amount (costs) on sale of assets | 2012-12-31 | $11,075,144 |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2012-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2012-12-31 | Disclaimer |
| Accountancy firm name | 2012-12-31 | KIRKLAND ALBRECHT & FREDRICKSON LLC |
| Accountancy firm EIN | 2012-12-31 | 043121055 |
| 2011 : VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2011 401k financial data | ||
| Unrealized appreciation/depreciation of other (non real estate) assets | 2011-12-31 | $-3,951,920 |
| Total unrealized appreciation/depreciation of assets | 2011-12-31 | $-3,951,920 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2011-12-31 | $0 |
| Total income from all sources (including contributions) | 2011-12-31 | $24,553,170 |
| Total loss/gain on sale of assets | 2011-12-31 | $1,683,815 |
| Total of all expenses incurred | 2011-12-31 | $7,511,654 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2011-12-31 | $7,501,276 |
| Value of total corrective distributions | 2011-12-31 | $3,216 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2011-12-31 | $31,409,212 |
| Value of total assets at end of year | 2011-12-31 | $175,220,758 |
| Value of total assets at beginning of year | 2011-12-31 | $158,179,242 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2011-12-31 | $7,162 |
| Total interest from all sources | 2011-12-31 | $78,755 |
| Total dividends received (eg from common stock, registered investment company shares) | 2011-12-31 | $4,219,348 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2011-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2011-12-31 | $4,219,348 |
| Was this plan covered by a fidelity bond | 2011-12-31 | Yes |
| Value of fidelity bond cover | 2011-12-31 | $5,000,000 |
| If this is an individual account plan, was there a blackout period | 2011-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2011-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2011-12-31 | No |
| Contributions received from participants | 2011-12-31 | $17,381,912 |
| Participant contributions at end of year | 2011-12-31 | $1,879,070 |
| Participant contributions at beginning of year | 2011-12-31 | $1,593,953 |
| Participant contributions at end of year | 2011-12-31 | $411,172 |
| Participant contributions at beginning of year | 2011-12-31 | $346,895 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2011-12-31 | $4,895,185 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2011-12-31 | $92 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2011-12-31 | $120 |
| Administrative expenses (other) incurred | 2011-12-31 | $7,162 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2011-12-31 | No |
| Value of net income/loss | 2011-12-31 | $17,041,516 |
| Value of net assets at end of year (total assets less liabilities) | 2011-12-31 | $175,220,758 |
| Value of net assets at beginning of year (total assets less liabilities) | 2011-12-31 | $158,179,242 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2011-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2011-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2011-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2011-12-31 | $123,419,399 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2011-12-31 | $108,560,413 |
| Interest on participant loans | 2011-12-31 | $77,459 |
| Value of interest in common/collective trusts at end of year | 2011-12-31 | $10,005,005 |
| Value of interest in common/collective trusts at beginning of year | 2011-12-31 | $8,120,741 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2011-12-31 | $714,131 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2011-12-31 | $589,583 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2011-12-31 | $589,583 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2011-12-31 | $1,296 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2011-12-31 | $-9,185,055 |
| Net investment gain or loss from common/collective trusts | 2011-12-31 | $299,015 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2011-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2011-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2011-12-31 | No |
| Assets. Invements in employer securities at end of year | 2011-12-31 | $36,500,015 |
| Assets. Invements in employer securities at beginning of year | 2011-12-31 | $37,281,658 |
| Contributions received in cash from employer | 2011-12-31 | $9,132,115 |
| Employer contributions (assets) at end of year | 2011-12-31 | $2,291,874 |
| Employer contributions (assets) at beginning of year | 2011-12-31 | $1,685,879 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2011-12-31 | $7,501,276 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2011-12-31 | No |
| Did the plan have assets held for investment | 2011-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2011-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2011-12-31 | No |
| Aggregate proceeds on sale of assets | 2011-12-31 | $7,268,886 |
| Aggregate carrying amount (costs) on sale of assets | 2011-12-31 | $5,585,071 |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2011-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2011-12-31 | Disclaimer |
| Accountancy firm name | 2011-12-31 | KIRKLAND ALBRECHT & FREDRICKSON LLC |
| Accountancy firm EIN | 2011-12-31 | 043121055 |
| 2010 : VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2010 401k financial data | ||
| Unrealized appreciation/depreciation of other (non real estate) assets | 2010-12-31 | $-7,449,816 |
| Total unrealized appreciation/depreciation of assets | 2010-12-31 | $-7,449,816 |
| Total liabilities at end of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2010-12-31 | $0 |
| Total liabilities at beginning of year (benefit claims payable, operating payabales, acquisition indebtedness and other liabilities) | 2010-12-31 | $17,725 |
| Total income from all sources (including contributions) | 2010-12-31 | $28,462,756 |
| Total loss/gain on sale of assets | 2010-12-31 | $-264,100 |
| Total of all expenses incurred | 2010-12-31 | $5,407,230 |
| Benefit payments and payments to participlants,beneficiaries,insurance carriers and others | 2010-12-31 | $5,397,837 |
| Value of total corrective distributions | 2010-12-31 | $690 |
| Total contributions o plan (from employers,participants, others, non cash contrinutions) | 2010-12-31 | $22,168,880 |
| Value of total assets at end of year | 2010-12-31 | $158,179,242 |
| Value of total assets at beginning of year | 2010-12-31 | $135,141,441 |
| Total of administrative expenses incurred including professional, contract, advisory and management fees | 2010-12-31 | $8,703 |
| Total interest from all sources | 2010-12-31 | $74,857 |
| Total dividends received (eg from common stock, registered investment company shares) | 2010-12-31 | $1,799,161 |
| Has a resolution to terminate the plan been adopted during the plan year or any prior plan year | 2010-12-31 | No |
| Total dividends received from registered investment company shares (eg mutual funds) | 2010-12-31 | $1,799,161 |
| Was this plan covered by a fidelity bond | 2010-12-31 | Yes |
| Value of fidelity bond cover | 2010-12-31 | $5,000,000 |
| If this is an individual account plan, was there a blackout period | 2010-12-31 | No |
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2010-12-31 | $0 |
| Were there any nonexempt tranactions with any party-in-interest | 2010-12-31 | No |
| Contributions received from participants | 2010-12-31 | $13,047,062 |
| Participant contributions at end of year | 2010-12-31 | $1,593,953 |
| Participant contributions at beginning of year | 2010-12-31 | $1,236,032 |
| Participant contributions at end of year | 2010-12-31 | $346,895 |
| Participant contributions at beginning of year | 2010-12-31 | $575,508 |
| Income. Received or receivable in cash from other sources (including rollovers) | 2010-12-31 | $2,297,056 |
| Value of other receiveables (less allowance for doubtful accounts) at end of year | 2010-12-31 | $120 |
| Value of other receiveables (less allowance for doubtful accounts) at beginning of year | 2010-12-31 | $138 |
| Administrative expenses (other) incurred | 2010-12-31 | $8,703 |
| Did the receive any noncash contributions whose value was neither redily determinable on an established market nor set by an independent third party appraiser | 2010-12-31 | No |
| Value of net income/loss | 2010-12-31 | $23,055,526 |
| Value of net assets at end of year (total assets less liabilities) | 2010-12-31 | $158,179,242 |
| Value of net assets at beginning of year (total assets less liabilities) | 2010-12-31 | $135,123,716 |
| Did the plan have a loss casued by fraud or dishonesty (regardless whether reimbursed by fidelity bond) | 2010-12-31 | No |
| Were any loans by the plan or fixed income obligations due to the plan in default | 2010-12-31 | No |
| Were any leases to which the plan was party in default or uncollectible | 2010-12-31 | No |
| Value of interest in registered invesment companies (eg mutual funds) at end of year | 2010-12-31 | $108,560,413 |
| Value of interest in registered invesment companies (eg mutual funds) at beginning of year | 2010-12-31 | $83,736,535 |
| Interest on participant loans | 2010-12-31 | $73,269 |
| Value of interest in common/collective trusts at end of year | 2010-12-31 | $8,120,741 |
| Value of interest in common/collective trusts at beginning of year | 2010-12-31 | $6,621,073 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at end of year | 2010-12-31 | $589,583 |
| Interest-bearing cash (include money market accounts & certificates of deposit) at beginning of the Year | 2010-12-31 | $808,989 |
| Value of interest bearing cash (including money market accounts and certificates of deposits) at beginning of year | 2010-12-31 | $808,989 |
| Interest earned from interest bearing cash (including money market accounts and certificates of deposit) | 2010-12-31 | $1,588 |
| Net investment gain/loss from registered investment companies (e.g. mutual funds) | 2010-12-31 | $11,841,490 |
| Net investment gain or loss from common/collective trusts | 2010-12-31 | $292,284 |
| Were any plan transactions or series of transactions in excess of 5% of the current value of the plan assets | 2010-12-31 | No |
| Was there a failure to transmit to the plan any participant contributions | 2010-12-31 | No |
| Has the plan failed to provide any benefit when due under the plan | 2010-12-31 | No |
| Assets. Invements in employer securities at end of year | 2010-12-31 | $37,281,658 |
| Assets. Invements in employer securities at beginning of year | 2010-12-31 | $40,750,393 |
| Contributions received in cash from employer | 2010-12-31 | $6,824,762 |
| Employer contributions (assets) at end of year | 2010-12-31 | $1,685,879 |
| Employer contributions (assets) at beginning of year | 2010-12-31 | $1,412,773 |
| Benefit payments and payments to provide benefits directly to participlants or beneficiaries including direct rollovers | 2010-12-31 | $5,397,837 |
| Was the provided the required notice or one of the exceptions to providing the black out period notice applied under 29 CFR 2520.101-3 | 2010-12-31 | No |
| Liabilities. Value of benefit claims payable at end of year | 2010-12-31 | $0 |
| Liabilities. Value of benefit claims payable at beginning of year | 2010-12-31 | $17,725 |
| Did the plan have assets held for investment | 2010-12-31 | Yes |
| Did the plan hold any assets whose current value was neither redily determinable on an established market nor set by an independent third party appraiser | 2010-12-31 | No |
| Were all the plan assets eitehr distributed to particpants/beneficiaries, transferred to another plan or brought under the control of the PBGC | 2010-12-31 | No |
| Aggregate proceeds on sale of assets | 2010-12-31 | $2,315,572 |
| Aggregate carrying amount (costs) on sale of assets | 2010-12-31 | $2,579,672 |
| Accountant perfomed limited scope audit pursuant to 29 CFR 2520.103-8 and/or 103-12(d) | 2010-12-31 | Yes |
| Opinion of an independent qualified public accountant for this plan | 2010-12-31 | Disclaimer |
| Accountancy firm name | 2010-12-31 | KIRKLAND ALBRECHT AND FREDRICKSON |
| Accountancy firm EIN | 2010-12-31 | 043121055 |
| 2009 : VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2009 401k financial data | ||
| Total value of distributions paid in property other than in cash, annuity contracts, or publicly traded employer securities | 2009-12-31 | $0 |
| 2023: VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2023 form 5500 responses | ||
|---|---|---|
| 2023-01-01 | Type of plan entity | Single employer plan |
| 2023-01-01 | Submission has been amended | No |
| 2023-01-01 | This submission is the final filing | No |
| 2023-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2023-01-01 | Plan is a collectively bargained plan | No |
| 2023-01-01 | Plan funding arrangement – Trust | Yes |
| 2023-01-01 | Plan benefit arrangement - Trust | Yes |
| 2022: VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2022 form 5500 responses | ||
| 2022-01-01 | Type of plan entity | Single employer plan |
| 2022-01-01 | Submission has been amended | No |
| 2022-01-01 | This submission is the final filing | No |
| 2022-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2022-01-01 | Plan is a collectively bargained plan | No |
| 2022-01-01 | Plan funding arrangement – Trust | Yes |
| 2022-01-01 | Plan benefit arrangement - Trust | Yes |
| 2021: VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2021 form 5500 responses | ||
| 2021-01-01 | Type of plan entity | Single employer plan |
| 2021-01-01 | Submission has been amended | No |
| 2021-01-01 | This submission is the final filing | No |
| 2021-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2021-01-01 | Plan is a collectively bargained plan | No |
| 2021-01-01 | Plan funding arrangement – Trust | Yes |
| 2021-01-01 | Plan benefit arrangement - Trust | Yes |
| 2020: VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2020 form 5500 responses | ||
| 2020-01-01 | Type of plan entity | Single employer plan |
| 2020-01-01 | Submission has been amended | No |
| 2020-01-01 | This submission is the final filing | No |
| 2020-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2020-01-01 | Plan is a collectively bargained plan | No |
| 2020-01-01 | Plan funding arrangement – Trust | Yes |
| 2020-01-01 | Plan benefit arrangement - Trust | Yes |
| 2019: VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2019 form 5500 responses | ||
| 2019-01-01 | Type of plan entity | Single employer plan |
| 2019-01-01 | Submission has been amended | No |
| 2019-01-01 | This submission is the final filing | No |
| 2019-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2019-01-01 | Plan is a collectively bargained plan | No |
| 2019-01-01 | Plan funding arrangement – Trust | Yes |
| 2019-01-01 | Plan benefit arrangement - Trust | Yes |
| 2018: VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2018 form 5500 responses | ||
| 2018-01-01 | Type of plan entity | Single employer plan |
| 2018-01-01 | Submission has been amended | No |
| 2018-01-01 | This submission is the final filing | No |
| 2018-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2018-01-01 | Plan is a collectively bargained plan | No |
| 2018-01-01 | Plan funding arrangement – Trust | Yes |
| 2018-01-01 | Plan benefit arrangement - Trust | Yes |
| 2017: VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2017 form 5500 responses | ||
| 2017-01-01 | Type of plan entity | Single employer plan |
| 2017-01-01 | Submission has been amended | No |
| 2017-01-01 | This submission is the final filing | No |
| 2017-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2017-01-01 | Plan is a collectively bargained plan | No |
| 2017-01-01 | Plan funding arrangement – Trust | Yes |
| 2017-01-01 | Plan benefit arrangement - Trust | Yes |
| 2016: VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2016 form 5500 responses | ||
| 2016-01-01 | Type of plan entity | Single employer plan |
| 2016-01-01 | Submission has been amended | No |
| 2016-01-01 | This submission is the final filing | No |
| 2016-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2016-01-01 | Plan is a collectively bargained plan | No |
| 2016-01-01 | Plan funding arrangement – Trust | Yes |
| 2016-01-01 | Plan benefit arrangement - Trust | Yes |
| 2015: VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2015 form 5500 responses | ||
| 2015-01-01 | Type of plan entity | Single employer plan |
| 2015-01-01 | Submission has been amended | No |
| 2015-01-01 | This submission is the final filing | No |
| 2015-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2015-01-01 | Plan is a collectively bargained plan | No |
| 2015-01-01 | Plan funding arrangement – Trust | Yes |
| 2015-01-01 | Plan benefit arrangement - Trust | Yes |
| 2014: VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2014 form 5500 responses | ||
| 2014-01-01 | Type of plan entity | Single employer plan |
| 2014-01-01 | Submission has been amended | No |
| 2014-01-01 | This submission is the final filing | No |
| 2014-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2014-01-01 | Plan is a collectively bargained plan | No |
| 2014-01-01 | Plan funding arrangement – Trust | Yes |
| 2014-01-01 | Plan benefit arrangement - Trust | Yes |
| 2013: VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2013 form 5500 responses | ||
| 2013-01-01 | Type of plan entity | Single employer plan |
| 2013-01-01 | Submission has been amended | No |
| 2013-01-01 | This submission is the final filing | No |
| 2013-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2013-01-01 | Plan is a collectively bargained plan | No |
| 2013-01-01 | Plan funding arrangement – Trust | Yes |
| 2013-01-01 | Plan benefit arrangement - Trust | Yes |
| 2012: VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2012 form 5500 responses | ||
| 2012-01-01 | Type of plan entity | Single employer plan |
| 2012-01-01 | Submission has been amended | No |
| 2012-01-01 | This submission is the final filing | No |
| 2012-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2012-01-01 | Plan is a collectively bargained plan | No |
| 2012-01-01 | Plan funding arrangement – Trust | Yes |
| 2012-01-01 | Plan benefit arrangement - Trust | Yes |
| 2011: VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2011 form 5500 responses | ||
| 2011-01-01 | Type of plan entity | Single employer plan |
| 2011-01-01 | First time form 5500 has been submitted | Yes |
| 2011-01-01 | Submission has been amended | No |
| 2011-01-01 | This submission is the final filing | No |
| 2011-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2011-01-01 | Plan is a collectively bargained plan | No |
| 2011-01-01 | Plan funding arrangement – Trust | Yes |
| 2011-01-01 | Plan benefit arrangement - Trust | Yes |
| 2009: VERTEX PHARMACEUTICALS, INCORPORATED 401(K) PLAN 2009 form 5500 responses | ||
| 2009-01-01 | Type of plan entity | Single employer plan |
| 2009-01-01 | Submission has been amended | No |
| 2009-01-01 | This submission is the final filing | No |
| 2009-01-01 | This return/report is a short plan year return/report (less than 12 months) | No |
| 2009-01-01 | Plan is a collectively bargained plan | No |
| 2009-01-01 | Plan funding arrangement – Trust | Yes |
| 2009-01-01 | Plan benefit arrangement - Trust | Yes |